|
NDC00270-0696-25
|
6505-01-153-3306
|
Diatrizoate Meglumine Injection |
Bracco Diagnostics Inc
|
|
Quote
|
|
NDC00003-0696-25
|
6505-01-153-3306
|
Diatrizoate Meglumine Injection |
Squibb E R and Sons Inc
|
|
Quote
|
|
CORTEF TABLETS
|
6505-01-153-3325
|
Usp Hydrocortisone Tablets |
Pharmacia & Upjohn Company
|
|
Quote
|
|
NDC00009-0031-01
|
6505-01-153-3325
|
Usp Hydrocortisone Tablets |
Pharmacia & Upjohn Company
|
|
Quote
|
|
NDC00009-0031-01
|
6505-01-153-3325
|
Usp Hydrocortisone Tablets |
Pfizer Inc.
|
|
Quote
|
|
CORTEF TABLETS
|
6505-01-153-3325
|
Usp Hydrocortisone Tablets |
Pharmacia & Upjohn Company
|
|
Quote
|
|
NDC00009-0031-01
|
6505-01-153-3325
|
Usp Hydrocortisone Tablets |
Pfizer Inc.
|
|
Quote
|
|
CORTEF TABLETS
|
6505-01-153-3325
|
Usp Hydrocortisone Tablets |
Pharmacia & Upjohn Company
|
|
Quote
|
|
NDC00009-0031-01
|
6505-01-153-3325
|
Usp Hydrocortisone Tablets |
Pfizer Inc.
|
|
Quote
|
|
CORTEF TABLETS
|
6505-01-153-3325
|
Usp Hydrocortisone Tablets |
Pharmacia & Upjohn Company
|
|
Quote
|
|
NDC00009-0031-01
|
6505-01-153-3325
|
Usp Hydrocortisone Tablets |
Pfizer Inc.
|
|
Quote
|
|
SENOKOT
|
6505-01-153-3334
|
Standardized Senna Fruit Extract |
The Frederick Purdue Company
|
|
Quote
|
|
034-1800-80
|
6505-01-153-3334
|
Standardized Senna Fruit Extract |
The Frederick Purdue Company
|
|
Quote
|
|
NDC00034-1800-80
|
6505-01-153-3334
|
Standardized Senna Fruit Extract |
The Frederick Purdue Company
|
|
Quote
|
|
SENOKOT SYRUP
|
6505-01-153-3334
|
Standardized Senna Fruit Extract |
The Frederick Purdue Company
|
|
Quote
|
|
SYNTHROID
|
6505-01-153-3338
|
Usp Levothyroxine Sodium Tablets |
Boots Pharmaceuticals Inc
|
|
Quote
|
|
SYNTHROID TABLETS
|
6505-01-153-3338
|
Usp Levothyroxine Sodium Tablets |
Boots Pharmaceuticals Inc
|
|
Quote
|
|
NDC00048-1090-05
|
6505-01-153-3338
|
Usp Levothyroxine Sodium Tablets |
Knoll Pharmaceuticals
|
|
Quote
|
|
NDC00074-7069-19
|
6505-01-153-3338
|
Usp Levothyroxine Sodium Tablets |
Abbott Laboratories Inc
|
|
Quote
|
|
NDC00074-7069-19
|
6505-01-153-3338
|
Usp Levothyroxine Sodium Tablets |
Abbott Laboratories
|
|
Quote
|
|
NDC00048-1090-05
|
6505-01-153-3338
|
Usp Levothyroxine Sodium Tablets |
Boots Pharmaceuticals Inc
|
|
Quote
|
|
SYNTHROID
|
6505-01-153-3338
|
Usp Levothyroxine Sodium Tablets |
Abbvie Us Llc
|
|
Quote
|
|
NDC00781-5187-10
|
6505-01-153-3338
|
Usp Levothyroxine Sodium Tablets |
Sandoz Inc.
|
|
Quote
|
|
NDC00378-1815-10
|
6505-01-153-3338
|
Usp Levothyroxine Sodium Tablets |
Mylan Pharmaceuticals Inc.
|
|
Quote
|
|
NDC00074-7069-19
|
6505-01-153-3338
|
Usp Levothyroxine Sodium Tablets |
Abbvie Us Llc
|
|
Quote
|
|
SYNTHROID
|
6505-01-153-3338
|
Usp Levothyroxine Sodium Tablets |
Abbvie Us Llc
|
|
Quote
|
|
NDC00781-5187-10
|
6505-01-153-3338
|
Usp Levothyroxine Sodium Tablets |
Sandoz Inc.
|
|
Quote
|
|
NDC00378-1815-10
|
6505-01-153-3338
|
Usp Levothyroxine Sodium Tablets |
Mylan Pharmaceuticals Inc.
|
|
Quote
|
|
NDC00074-7069-19
|
6505-01-153-3338
|
Usp Levothyroxine Sodium Tablets |
Abbvie Us Llc
|
|
Quote
|
|
SYNTHROID
|
6505-01-153-3338
|
Usp Levothyroxine Sodium Tablets |
Abbvie Us Llc
|
|
Quote
|
|
NDC00781-5187-10
|
6505-01-153-3338
|
Usp Levothyroxine Sodium Tablets |
Sandoz Inc.
|
|
Quote
|
|
NDC00378-1815-10
|
6505-01-153-3338
|
Usp Levothyroxine Sodium Tablets |
Mylan Pharmaceuticals Inc.
|
|
Quote
|
|
NDC00074-7069-19
|
6505-01-153-3338
|
Usp Levothyroxine Sodium Tablets |
Abbvie Us Llc
|
|
Quote
|
|
NAVANE
|
6505-01-153-3343
|
Usp Thiothixene Capsules |
Roerig Div Pfizer Inc
|
|
Quote
|
|
NAVANE CAPSULES
|
6505-01-153-3343
|
Usp Thiothixene Capsules |
Roerig Div Pfizer Inc
|
|
Quote
|
|
NDC00049-5720-66
|
6505-01-153-3343
|
Usp Thiothixene Capsules |
Roerig Div Pfizer Inc
|
|
Quote
|
|
NAVANE
|
6505-01-153-3343
|
Usp Thiothixene Capsules |
Roerig Div Pfizer Inc
|
|
Quote
|
|
NAVANE CAPSULES
|
6505-01-153-3343
|
Usp Thiothixene Capsules |
Roerig Div Pfizer Inc
|
|
Quote
|
|
NDC00049-5720-66
|
6505-01-153-3343
|
Usp Thiothixene Capsules |
Roerig Div Pfizer Inc
|
|
Quote
|
|
NAVANE
|
6505-01-153-3343
|
Usp Thiothixene Capsules |
Roerig Div Pfizer Inc
|
|
Quote
|
|
NAVANE CAPSULES
|
6505-01-153-3343
|
Usp Thiothixene Capsules |
Roerig Div Pfizer Inc
|
|
Quote
|
|
NDC00049-5720-66
|
6505-01-153-3343
|
Usp Thiothixene Capsules |
Roerig Div Pfizer Inc
|
|
Quote
|
|
NAVANE
|
6505-01-153-3343
|
Usp Thiothixene Capsules |
Roerig Div Pfizer Inc
|
|
Quote
|
|
NAVANE CAPSULES
|
6505-01-153-3343
|
Usp Thiothixene Capsules |
Roerig Div Pfizer Inc
|
|
Quote
|
|
NDC00049-5720-66
|
6505-01-153-3343
|
Usp Thiothixene Capsules |
Roerig Div Pfizer Inc
|
|
Quote
|
|
ARISTOSPAN
|
6505-01-153-3350
|
Triamcinolone Hexacetonide Injec |
Sab Pharma
|
|
Quote
|
|
ARISTOSPAN SUSPENSION
|
6505-01-153-3350
|
Triamcinolone Hexacetonide Injec |
Sab Pharma
|
|
Quote
|
|
NDC54643-1055-00
|
6505-01-153-3350
|
Triamcinolone Hexacetonide Injec |
Sab Pharma
|
|
Quote
|
|
ARISTOSPAN
|
6505-01-153-3350
|
Triamcinolone Hexacetonide Injec |
Sab Pharma
|
|
Quote
|
|
ARISTOSPAN SUSPENSION
|
6505-01-153-3350
|
Triamcinolone Hexacetonide Injec |
Sab Pharma
|
|
Quote
|
|
NDC54643-1055-00
|
6505-01-153-3350
|
Triamcinolone Hexacetonide Injec |
Sab Pharma
|
|
Quote
|
|
ARISTOSPAN
|
6505-01-153-3350
|
Triamcinolone Hexacetonide Injec |
Sab Pharma
|
|
Quote
|
|
ARISTOSPAN SUSPENSION
|
6505-01-153-3350
|
Triamcinolone Hexacetonide Injec |
Sab Pharma
|
|
Quote
|
|
NDC54643-1055-00
|
6505-01-153-3350
|
Triamcinolone Hexacetonide Injec |
Sab Pharma
|
|
Quote
|
|
ARISTOSPAN
|
6505-01-153-3350
|
Triamcinolone Hexacetonide Injec |
Sab Pharma
|
|
Quote
|
|
ARISTOSPAN SUSPENSION
|
6505-01-153-3350
|
Triamcinolone Hexacetonide Injec |
Sab Pharma
|
|
Quote
|
|
NDC54643-1055-00
|
6505-01-153-3350
|
Triamcinolone Hexacetonide Injec |
Sab Pharma
|
|
Quote
|
|
NDC--0058-0725-15#
|
6505-01-153-3370
|
Methylcellulose Oph |
Cooper Laboratories Inc
|
|
Quote
|
|
650500C994668#
|
6505-01-153-3370
|
Methylcellulose Oph |
Defense Logistics Agency
|
|
Quote
|
|
NDC00071-0418-13
|
6505-01-153-3370
|
Methylcellulose Oph |
Cardinal Health 100 Inc
|
|
Quote
|
|
650500C994668#
|
6505-01-153-3370
|
Methylcellulose Oph |
Defense Logistics Agency
|
|
Quote
|
|
NDC00071-0418-13
|
6505-01-153-3370
|
Methylcellulose Oph |
Cardinal Health 100 Inc
|
|
Quote
|
|
NDC--0058-0725-15#
|
6505-01-153-3370
|
Methylcellulose Oph |
Cooper Laboratories Inc
|
|
Quote
|
|
650500C994668#
|
6505-01-153-3370
|
Methylcellulose Oph |
Defense Logistics Agency
|
|
Quote
|
|
NDC00071-0418-13
|
6505-01-153-3370
|
Methylcellulose Oph |
Cardinal Health 100 Inc
|
|
Quote
|
|
NDC--0058-0725-15#
|
6505-01-153-3370
|
Methylcellulose Oph |
Cooper Laboratories Inc
|
|
Quote
|
|
650500C994668#
|
6505-01-153-3370
|
Methylcellulose Oph |
Defense Logistics Agency
|
|
Quote
|
|
NDC00071-0418-13
|
6505-01-153-3370
|
Methylcellulose Oph |
Cardinal Health 100 Inc
|
|
Quote
|
|
NDC--0058-0725-15#
|
6505-01-153-3370
|
Methylcellulose Oph |
Cooper Laboratories Inc
|
|
Quote
|
|
NDC00395-0725-01
|
6505-01-153-3375
|
Usp Dextrose |
Amerisourcebergen Drug Corporation
|
|
Quote
|
|
4908-030
|
6505-01-153-3375
|
Usp Dextrose |
Mallinckrodt Inc
|
|
Quote
|
|
DEXTROSE
|
6505-01-153-3375
|
Usp Dextrose |
Walmead Inc
|
|
Quote
|
|
NDC00395-0725-01
|
6505-01-153-3375
|
Usp Dextrose |
Walmead Inc
|
|
Quote
|
|
NDC00395-0725-01
|
6505-01-153-3375
|
Usp Dextrose |
Amerisourcebergen Drug Corporation
|
|
Quote
|
|
4908-030
|
6505-01-153-3375
|
Usp Dextrose |
Mallinckrodt Inc
|
|
Quote
|
|
DEXTROSE
|
6505-01-153-3375
|
Usp Dextrose |
Walmead Inc
|
|
Quote
|
|
NDC00395-0725-01
|
6505-01-153-3375
|
Usp Dextrose |
Walmead Inc
|
|
Quote
|
|
NDC00395-0725-01
|
6505-01-153-3375
|
Usp Dextrose |
Amerisourcebergen Drug Corporation
|
|
Quote
|
|
4908-030
|
6505-01-153-3375
|
Usp Dextrose |
Mallinckrodt Inc
|
|
Quote
|
|
DEXTROSE
|
6505-01-153-3375
|
Usp Dextrose |
Walmead Inc
|
|
Quote
|
|
NDC00395-0725-01
|
6505-01-153-3375
|
Usp Dextrose |
Walmead Inc
|
|
Quote
|
|
NDC00395-0725-01
|
6505-01-153-3375
|
Usp Dextrose |
Amerisourcebergen Drug Corporation
|
|
Quote
|
|
4908-030
|
6505-01-153-3375
|
Usp Dextrose |
Mallinckrodt Inc
|
|
Quote
|
|
DEXTROSE
|
6505-01-153-3375
|
Usp Dextrose |
Walmead Inc
|
|
Quote
|
|
NDC00395-0725-01
|
6505-01-153-3375
|
Usp Dextrose |
Walmead Inc
|
|
Quote
|
|
NITROSTAT
|
6505-01-153-3379
|
Usp Nitroglycerin Tablets |
Pfizer Inc.
|
|
Quote
|
|
03-0001
|
6505-01-153-3379
|
Usp Nitroglycerin Tablets |
Defense Logistics Agency
|
|
Quote
|
|
NDC00071-0418-13
|
6505-01-153-3379
|
Usp Nitroglycerin Tablets |
Pfizer Inc.
|
|
Quote
|
|
NDC00071-0418-13
|
6505-01-153-3379
|
Usp Nitroglycerin Tablets |
Veterans Health
|
|
Quote
|
|
D
|
6505-01-153-3379
|
Usp Nitroglycerin Tablets |
Veterans Health
|
|
Quote
|
|
NITROSTAT
|
6505-01-153-3379
|
Usp Nitroglycerin Tablets |
Pfizer Inc.
|
|
Quote
|
|
03-0001
|
6505-01-153-3379
|
Usp Nitroglycerin Tablets |
Defense Logistics Agency
|
|
Quote
|
|
NDC00071-0418-13
|
6505-01-153-3379
|
Usp Nitroglycerin Tablets |
Pfizer Inc.
|
|
Quote
|
|
NDC00071-0418-13
|
6505-01-153-3379
|
Usp Nitroglycerin Tablets |
Veterans Health
|
|
Quote
|
|
D
|
6505-01-153-3379
|
Usp Nitroglycerin Tablets |
Veterans Health
|
|
Quote
|
|
NITROSTAT
|
6505-01-153-3379
|
Usp Nitroglycerin Tablets |
Pfizer Inc.
|
|
Quote
|
|
03-0001
|
6505-01-153-3379
|
Usp Nitroglycerin Tablets |
Defense Logistics Agency
|
|
Quote
|
|
NDC00071-0418-13
|
6505-01-153-3379
|
Usp Nitroglycerin Tablets |
Pfizer Inc.
|
|
Quote
|
|
NDC00071-0418-13
|
6505-01-153-3379
|
Usp Nitroglycerin Tablets |
Veterans Health
|
|
Quote
|
|
D
|
6505-01-153-3379
|
Usp Nitroglycerin Tablets |
Veterans Health
|
|
Quote
|
|
NITROSTAT
|
6505-01-153-3379
|
Usp Nitroglycerin Tablets |
Pfizer Inc.
|
|
Quote
|
|
03-0001
|
6505-01-153-3379
|
Usp Nitroglycerin Tablets |
Defense Logistics Agency
|
|
Quote
|
|
NDC00071-0418-13
|
6505-01-153-3379
|
Usp Nitroglycerin Tablets |
Pfizer Inc.
|
|
Quote
|
|
D
|
6505-01-153-3379
|
Usp Nitroglycerin Tablets |
Veterans Health
|
|
Quote
|
|
NDC00071-0418-13
|
6505-01-153-3379
|
Usp Nitroglycerin Tablets |
Veterans Health
|
|
Quote
|
|
DANTRIUM
|
6505-01-153-3380
|
Dantrolene Sodium Capsules |
Procter & Gamble Pharmaceuticals
|
|
Quote
|
|
DANTRIUM CAPSULES
|
6505-01-153-3380
|
Dantrolene Sodium Capsules |
Procter & Gamble Pharmaceuticals
|
|
Quote
|
|
NDC00149-0030-66
|
6505-01-153-3380
|
Dantrolene Sodium Capsules |
Procter & Gamble Pharmaceuticals
|
|
Quote
|
|
DANTRIUM
|
6505-01-153-3380
|
Dantrolene Sodium Capsules |
Procter & Gamble Pharmaceuticals
|
|
Quote
|
|
DANTRIUM CAPSULES
|
6505-01-153-3380
|
Dantrolene Sodium Capsules |
Procter & Gamble Pharmaceuticals
|
|
Quote
|
|
NDC00149-0030-66
|
6505-01-153-3380
|
Dantrolene Sodium Capsules |
Procter & Gamble Pharmaceuticals
|
|
Quote
|
|
DANTRIUM
|
6505-01-153-3380
|
Dantrolene Sodium Capsules |
Procter & Gamble Pharmaceuticals
|
|
Quote
|
|
DANTRIUM CAPSULES
|
6505-01-153-3380
|
Dantrolene Sodium Capsules |
Procter & Gamble Pharmaceuticals
|
|
Quote
|
|
NDC00149-0030-66
|
6505-01-153-3380
|
Dantrolene Sodium Capsules |
Procter & Gamble Pharmaceuticals
|
|
Quote
|
|
DANTRIUM
|
6505-01-153-3380
|
Dantrolene Sodium Capsules |
Procter & Gamble Pharmaceuticals
|
|
Quote
|
|
DANTRIUM CAPSULES
|
6505-01-153-3380
|
Dantrolene Sodium Capsules |
Procter & Gamble Pharmaceuticals
|
|
Quote
|
|
NDC00149-0030-66
|
6505-01-153-3380
|
Dantrolene Sodium Capsules |
Procter & Gamble Pharmaceuticals
|
|
Quote
|
|
NDC00006-0097-50
|
6505-01-153-3386
|
Usp Dexamethasone Tablets |
Merck Sharp & Dohme Corp.
|
|
Quote
|
|
NDC00054-4527-31
|
6505-01-153-3389
|
Usp Lithium Carbonate Tablets |
Boehringer Ingelheim Roxane, Inc.
|
|
Quote
|
|
NDC00054-4524-31
|
6505-01-153-3389
|
Usp Lithium Carbonate Tablets |
Boehringer Ingelheim Roxane, Inc.
|
|
Quote
|
|
NDC00054-4527-31
|
6505-01-153-3389
|
Usp Lithium Carbonate Tablets |
Radiac Abrasives Inc
|
|
Quote
|
|
NDC54868-1335-00
|
6505-01-153-3389
|
Usp Lithium Carbonate Tablets |
Medical and Safety Group Inc
|
|
Quote
|
|
LITHOTABS
|
6505-01-153-3389
|
Usp Lithium Carbonate Tablets |
Solvay Pharmaceuticals Inc.
|
|
Quote
|
|
NDC00032-7516-10
|
6505-01-153-3389
|
Usp Lithium Carbonate Tablets |
Solvay Pharmaceuticals Inc.
|
|
Quote
|
|
NDC00998-0408-15
|
6505-01-153-3391
|
Hydroxypropyl Methylcellulose Op |
Alcon Laboratories, Inc.
|
|
Quote
|
|
ISOPTO PLAIN
|
6505-01-153-3391
|
Hydroxypropyl Methylcellulose Op |
Alcon Laboratories, Inc.
|
|
Quote
|
|
ISOPTO TEARS
|
6505-01-153-3391
|
Hydroxypropyl Methylcellulose Op |
Alcon Laboratories, Inc.
|
|
Quote
|
|
LACRIL SOLUTION
|
6505-01-153-3391
|
Hydroxypropyl Methylcellulose Op |
Allergan Inc
|
|
Quote
|
|
NDC00998-0404-15
|
6505-01-153-3391
|
Hydroxypropyl Methylcellulose Op |
Alcon Laboratories, Inc.
|
|
Quote
|
|
NDC11980-0045-15
|
6505-01-153-3391
|
Hydroxypropyl Methylcellulose Op |
Allergan Inc
|
|
Quote
|
|
NDC00058-0725-15
|
6505-01-153-3391
|
Hydroxypropyl Methylcellulose Op |
Iolab Corp
|
|
Quote
|
|
NDC58768-0725-15
|
6505-01-153-3391
|
Hydroxypropyl Methylcellulose Op |
Iolab Corp
|
|
Quote
|
|
ISOPTO PLAIN
|
6505-01-153-3391
|
Hydroxypropyl Methylcellulose Op |
Alcon Laboratories, Inc.
|
|
Quote
|
|
ISOPTO TEARS
|
6505-01-153-3391
|
Hydroxypropyl Methylcellulose Op |
Alcon Laboratories, Inc.
|
|
Quote
|
|
LACRIL SOLUTION
|
6505-01-153-3391
|
Hydroxypropyl Methylcellulose Op |
Allergan Inc
|
|
Quote
|
|
NDC00998-0408-15
|
6505-01-153-3391
|
Hydroxypropyl Methylcellulose Op |
Alcon Laboratories, Inc.
|
|
Quote
|
|
NDC58768-0725-15
|
6505-01-153-3391
|
Hydroxypropyl Methylcellulose Op |
Iolab Corp
|
|
Quote
|
|
NDC00058-0725-15
|
6505-01-153-3391
|
Hydroxypropyl Methylcellulose Op |
Iolab Corp
|
|
Quote
|
|
NDC00998-0404-15
|
6505-01-153-3391
|
Hydroxypropyl Methylcellulose Op |
Alcon Laboratories, Inc.
|
|
Quote
|
|
NDC11980-0045-15
|
6505-01-153-3391
|
Hydroxypropyl Methylcellulose Op |
Allergan Inc
|
|
Quote
|
|
ISOPTO PLAIN
|
6505-01-153-3391
|
Hydroxypropyl Methylcellulose Op |
Alcon Laboratories, Inc.
|
|
Quote
|
|
ISOPTO TEARS
|
6505-01-153-3391
|
Hydroxypropyl Methylcellulose Op |
Alcon Laboratories, Inc.
|
|
Quote
|
|
LACRIL SOLUTION
|
6505-01-153-3391
|
Hydroxypropyl Methylcellulose Op |
Allergan Inc
|
|
Quote
|
|
NDC00998-0408-15
|
6505-01-153-3391
|
Hydroxypropyl Methylcellulose Op |
Alcon Laboratories, Inc.
|
|
Quote
|
|
NDC58768-0725-15
|
6505-01-153-3391
|
Hydroxypropyl Methylcellulose Op |
Iolab Corp
|
|
Quote
|
|
NDC00058-0725-15
|
6505-01-153-3391
|
Hydroxypropyl Methylcellulose Op |
Iolab Corp
|
|
Quote
|
|
NDC00998-0404-15
|
6505-01-153-3391
|
Hydroxypropyl Methylcellulose Op |
Alcon Laboratories, Inc.
|
|
Quote
|
|
NDC11980-0045-15
|
6505-01-153-3391
|
Hydroxypropyl Methylcellulose Op |
Allergan Inc
|
|
Quote
|
|
ISOPTO PLAIN
|
6505-01-153-3391
|
Hydroxypropyl Methylcellulose Op |
Alcon Laboratories, Inc.
|
|
Quote
|
|
ISOPTO TEARS
|
6505-01-153-3391
|
Hydroxypropyl Methylcellulose Op |
Alcon Laboratories, Inc.
|
|
Quote
|
|
LACRIL SOLUTION
|
6505-01-153-3391
|
Hydroxypropyl Methylcellulose Op |
Allergan Inc
|
|
Quote
|
|
NDC00998-0408-15
|
6505-01-153-3391
|
Hydroxypropyl Methylcellulose Op |
Alcon Laboratories, Inc.
|
|
Quote
|
|
NDC58768-0725-15
|
6505-01-153-3391
|
Hydroxypropyl Methylcellulose Op |
Iolab Corp
|
|
Quote
|
|
NDC00058-0725-15
|
6505-01-153-3391
|
Hydroxypropyl Methylcellulose Op |
Iolab Corp
|
|
Quote
|
|
NDC00998-0404-15
|
6505-01-153-3391
|
Hydroxypropyl Methylcellulose Op |
Alcon Laboratories, Inc.
|
|
Quote
|
|
NDC11980-0045-15
|
6505-01-153-3391
|
Hydroxypropyl Methylcellulose Op |
Allergan Inc
|
|
Quote
|
|
NDC00173-0880-25
|
6505-01-153-3394
|
Usp Thioguanine Tablets |
Glaxo Wellcome Inc
|
|
Quote
|
|
NDC00173-0880-25
|
6505-01-153-3394
|
Usp Thioguanine Tablets |
Burroughs Wellcome Co
|
|
Quote
|
|
NDC00081-0880-25
|
6505-01-153-3394
|
Usp Thioguanine Tablets |
Burroughs Wellcome Co
|
|
Quote
|
|
NDC00904-2735-15
|
6505-01-153-3395
|
Trimethobenzamide Hydrochloride |
Major Pharmaceuticals Inc
|
|
Quote
|
|
NDC45802-0723-90
|
6505-01-153-3395
|
Trimethobenzamide Hydrochloride |
Clay-park Laboratories Inc
|
|
Quote
|
|
NDC00029-4088-38
|
6505-01-153-3395
|
Trimethobenzamide Hydrochloride |
King Pharmaceuticals Inc
|
|
Quote
|
|
NDC45802-0723-90
|
6505-01-153-3395
|
Trimethobenzamide Hydrochloride |
Clay-park Laboratories Inc
|
|
Quote
|
|
NDC00029-4088-38
|
6505-01-153-3395
|
Trimethobenzamide Hydrochloride |
King Pharmaceuticals Inc
|
|
Quote
|
|
NDC00904-2735-15
|
6505-01-153-3395
|
Trimethobenzamide Hydrochloride |
Major Pharmaceuticals Inc
|
|
Quote
|
|
NDC45802-0723-90
|
6505-01-153-3395
|
Trimethobenzamide Hydrochloride |
Clay-park Laboratories Inc
|
|
Quote
|
|
NDC00029-4088-38
|
6505-01-153-3395
|
Trimethobenzamide Hydrochloride |
King Pharmaceuticals Inc
|
|
Quote
|
|
NDC00904-2735-15
|
6505-01-153-3395
|
Trimethobenzamide Hydrochloride |
Major Pharmaceuticals Inc
|
|
Quote
|
|
NDC45802-0723-90
|
6505-01-153-3395
|
Trimethobenzamide Hydrochloride |
Clay-park Laboratories Inc
|
|
Quote
|
|
NDC00029-4088-38
|
6505-01-153-3395
|
Trimethobenzamide Hydrochloride |
King Pharmaceuticals Inc
|
|
Quote
|
|
NDC00904-2735-15
|
6505-01-153-3395
|
Trimethobenzamide Hydrochloride |
Major Pharmaceuticals Inc
|
|
Quote
|
|
ANCOBON
|
6505-01-153-3401
|
Usp Flucytosine Capsules |
Hoffmann-la Roche Inc.
|
|
Quote
|
|
ANCOBON CAPSULES
|
6505-01-153-3401
|
Usp Flucytosine Capsules |
Hoffmann-la Roche Inc.
|
|
Quote
|
|
NDC00004-0079-01
|
6505-01-153-3401
|
Usp Flucytosine Capsules |
Hoffmann-la Roche Inc.
|
|
Quote
|
|
ANCOBON
|
6505-01-153-3401
|
Usp Flucytosine Capsules |
Hoffmann-la Roche Inc.
|
|
Quote
|
|
ANCOBON CAPSULES
|
6505-01-153-3401
|
Usp Flucytosine Capsules |
Hoffmann-la Roche Inc.
|
|
Quote
|
|
NDC00004-0079-01
|
6505-01-153-3401
|
Usp Flucytosine Capsules |
Hoffmann-la Roche Inc.
|
|
Quote
|
|
ANCOBON
|
6505-01-153-3401
|
Usp Flucytosine Capsules |
Hoffmann-la Roche Inc.
|
|
Quote
|
|
ANCOBON CAPSULES
|
6505-01-153-3401
|
Usp Flucytosine Capsules |
Hoffmann-la Roche Inc.
|
|
Quote
|
|
NDC00004-0079-01
|
6505-01-153-3401
|
Usp Flucytosine Capsules |
Hoffmann-la Roche Inc.
|
|
Quote
|
|
ANCOBON
|
6505-01-153-3401
|
Usp Flucytosine Capsules |
Hoffmann-la Roche Inc.
|
|
Quote
|
|
ANCOBON CAPSULES
|
6505-01-153-3401
|
Usp Flucytosine Capsules |
Hoffmann-la Roche Inc.
|
|
Quote
|
|
NDC00004-0079-01
|
6505-01-153-3401
|
Usp Flucytosine Capsules |
Hoffmann-la Roche Inc.
|
|
Quote
|
|
NDC54569-2830-00
|
6505-01-153-3411
|
Usp Hydrocortisone Lotion |
Merck Sharp & Dohme Corp.
|
|
Quote
|
|
NDC54569-2830-00
|
6505-01-153-3411
|
Usp Hydrocortisone Lotion |
Allscripts Healthcare Solutions Inc
|
|
Quote
|
|
NDC45802-0283-06
|
6505-01-153-3411
|
Usp Hydrocortisone Lotion |
Clay-park Laboratories Inc
|
|
Quote
|
|
NDC00182-5013-37
|
6505-01-153-3411
|
Usp Hydrocortisone Lotion |
Goldline Laboratories Inc.
|
|
Quote
|
|
NDC00066-0090-04
|
6505-01-153-3411
|
Usp Hydrocortisone Lotion |
Dermik Laboratories Inc
|
|
Quote
|
|
NDC52152-0014-02
|
6505-01-153-3426
|
Dexchlorpheniramine Maleate Exte |
Amide Pharmaceutical Inc
|
|
Quote
|
|
NDC00327-0001-10
|
6505-01-153-3432
|
Oxychlorosene Sodium For Solutio |
United-guardian Inc
|
|
Quote
|
|
NDC00327-0001-10
|
6505-01-153-3432
|
Oxychlorosene Sodium For Solutio |
United-guardian Inc
|
|
Quote
|
|
NDC00327-0001-10
|
6505-01-153-3432
|
Oxychlorosene Sodium For Solutio |
United-guardian Inc
|
|
Quote
|
|
NDC00327-0001-10
|
6505-01-153-3432
|
Oxychlorosene Sodium For Solutio |
United-guardian Inc
|
|
Quote
|
|
AVENTYL
|
6505-01-153-3439
|
Nortriptyline Hydrochloride Caps |
Eli Lilly and Company
|
|
Quote
|
|
AVENTYL CAPSULES
|
6505-01-153-3439
|
Nortriptyline Hydrochloride Caps |
Eli Lilly and Company
|
|
Quote
|
|
NDC00002-0817-03
|
6505-01-153-3439
|
Nortriptyline Hydrochloride Caps |
Eli Lilly and Company
|
|
Quote
|
|
AVENTYL
|
6505-01-153-3439
|
Nortriptyline Hydrochloride Caps |
Eli Lilly and Company
|
|
Quote
|
|
AVENTYL CAPSULES
|
6505-01-153-3439
|
Nortriptyline Hydrochloride Caps |
Eli Lilly and Company
|
|
Quote
|
|
NDC00002-0817-03
|
6505-01-153-3439
|
Nortriptyline Hydrochloride Caps |
Eli Lilly and Company
|
|
Quote
|
|
AVENTYL
|
6505-01-153-3439
|
Nortriptyline Hydrochloride Caps |
Eli Lilly and Company
|
|
Quote
|
|
AVENTYL CAPSULES
|
6505-01-153-3439
|
Nortriptyline Hydrochloride Caps |
Eli Lilly and Company
|
|
Quote
|
|
NDC00002-0817-03
|
6505-01-153-3439
|
Nortriptyline Hydrochloride Caps |
Eli Lilly and Company
|
|
Quote
|
|
AVENTYL
|
6505-01-153-3439
|
Nortriptyline Hydrochloride Caps |
Eli Lilly and Company
|
|
Quote
|
|
AVENTYL CAPSULES
|
6505-01-153-3439
|
Nortriptyline Hydrochloride Caps |
Eli Lilly and Company
|
|
Quote
|
|
NDC00002-0817-03
|
6505-01-153-3439
|
Nortriptyline Hydrochloride Caps |
Eli Lilly and Company
|
|
Quote
|
|
ITEM NUMBER: 5367
|
6505-01-153-3440
|
Usp Ferric Subsulfate Solution |
Fagron Inc.
|
|
Quote
|
|
F-1305
|
6505-01-153-3440
|
Usp Ferric Subsulfate Solution |
Spectrum Laboratory Products, Inc.
|
|
Quote
|
|
NDC49452-3081-02
|
6505-01-153-3440
|
Usp Ferric Subsulfate Solution |
Spectrum Laboratory Products, Inc.
|
|
Quote
|
|
MONSELS SOLUTION
|
6505-01-153-3440
|
Usp Ferric Subsulfate Solution |
Fagron Inc.
|
|
Quote
|
|
NDC38779-1284-08
|
6505-01-153-3440
|
Usp Ferric Subsulfate Solution |
Medisca Inc.
|
|
Quote
|
|
805132
|
6505-01-153-3440
|
Usp Ferric Subsulfate Solution |
Fagron Inc.
|
|
Quote
|
|
NDC51552-0357-05
|
6505-01-153-3440
|
Usp Ferric Subsulfate Solution |
Fagron Inc.
|
|
Quote
|
|
MONSELS SOLUTION
|
6505-01-153-3440
|
Usp Ferric Subsulfate Solution |
Fagron Inc.
|
|
Quote
|
|
1284
|
6505-01-153-3440
|
Usp Ferric Subsulfate Solution |
Medisca Inc.
|
|
Quote
|
|
NDC38779-1284-08
|
6505-01-153-3440
|
Usp Ferric Subsulfate Solution |
Medisca Inc.
|
|
Quote
|
|
805132
|
6505-01-153-3440
|
Usp Ferric Subsulfate Solution |
Fagron Inc.
|
|
Quote
|
|
NDC51552-0357-05
|
6505-01-153-3440
|
Usp Ferric Subsulfate Solution |
Fagron Inc.
|
|
Quote
|
|
MONSELS SOLUTION
|
6505-01-153-3440
|
Usp Ferric Subsulfate Solution |
Fagron Inc.
|
|
Quote
|
|
1284
|
6505-01-153-3440
|
Usp Ferric Subsulfate Solution |
Medisca Inc.
|
|
Quote
|
|
NDC38779-1284-08
|
6505-01-153-3440
|
Usp Ferric Subsulfate Solution |
Medisca Inc.
|
|
Quote
|
|
805132
|
6505-01-153-3440
|
Usp Ferric Subsulfate Solution |
Fagron Inc.
|
|
Quote
|
|
NDC51552-0357-05
|
6505-01-153-3440
|
Usp Ferric Subsulfate Solution |
Fagron Inc.
|
|
Quote
|
|
MONSELS SOLUTION
|
6505-01-153-3440
|
Usp Ferric Subsulfate Solution |
Fagron Inc.
|
|
Quote
|
|
1284
|
6505-01-153-3440
|
Usp Ferric Subsulfate Solution |
Medisca Inc.
|
|
Quote
|
|
NDC38779-1284-08
|
6505-01-153-3440
|
Usp Ferric Subsulfate Solution |
Medisca Inc.
|
|
Quote
|
|
AMOXIL
|
6505-01-153-3442
|
Amoxicillin For Oral Suspension |
Teva Pharmaceuticals Usa, Inc.
|
|
Quote
|
|
AMOXIL SUSPENSION
|
6505-01-153-3442
|
Amoxicillin For Oral Suspension |
Teva Pharmaceuticals Usa, Inc.
|
|
Quote
|
|
NDC00093-4155-79
|
6505-01-153-3442
|
Amoxicillin For Oral Suspension |
Teva Pharmaceuticals Usa, Inc.
|
|
Quote
|
|
ANCOBON CAPSULES
|
6505-01-153-3444
|
Usp Flucytosine Capsules |
Hoffmann-la Roche Inc.
|
|
Quote
|
|
ANCOBON
|
6505-01-153-3444
|
Usp Flucytosine Capsules |
R a C E Inc
|
|
Quote
|
|
NDC00004-0077-01
|
6505-01-153-3444
|
Usp Flucytosine Capsules |
Hoffmann-la Roche Inc.
|
|
Quote
|
|
DEMEROL
|
6505-01-153-3448
|
U Meperidine Hydrochloride Syrup |
Sanofi Inc
|
|
Quote
|
|
DEMEROL HCL SYRUP
|
6505-01-153-3448
|
U Meperidine Hydrochloride Syrup |
Sanofi Inc
|
|
Quote
|
|
DEMEROL SYRUP
|
6505-01-153-3448
|
U Meperidine Hydrochloride Syrup |
Sanofi Inc
|
|
Quote
|
|
97-0439
|
6505-01-153-3448
|
U Meperidine Hydrochloride Syrup |
Defense Logistics Agency
|
|
Quote
|
|
NDC00024-0332-06
|
6505-01-153-3448
|
U Meperidine Hydrochloride Syrup |
Sanofi Inc
|
|
Quote
|
|
NDC00054-3545-63
|
6505-01-153-3448
|
U Meperidine Hydrochloride Syrup |
Boehringer Ingelheim Roxane, Inc.
|
|
Quote
|
|
97-0439
|
6505-01-153-3448
|
U Meperidine Hydrochloride Syrup |
Defense Logistics Agency
|
|
Quote
|
|
NDC00054-3545-63
|
6505-01-153-3448
|
U Meperidine Hydrochloride Syrup |
Boehringer Ingelheim Roxane, Inc.
|
|
Quote
|
|
97-0439
|
6505-01-153-3448
|
U Meperidine Hydrochloride Syrup |
Defense Logistics Agency
|
|
Quote
|
|
NDC00054-3545-63
|
6505-01-153-3448
|
U Meperidine Hydrochloride Syrup |
Boehringer Ingelheim Roxane, Inc.
|
|
Quote
|
|
97-0439
|
6505-01-153-3448
|
U Meperidine Hydrochloride Syrup |
Defense Logistics Agency
|
|
Quote
|
|
NDC00054-3545-63
|
6505-01-153-3448
|
U Meperidine Hydrochloride Syrup |
Boehringer Ingelheim Roxane, Inc.
|
|
Quote
|
|
NDC00026-0613-20
|
6505-01-153-3452
|
Usp Plasma Protein Fraction |
Talecris Biotherapeutics Holdings
|
|
Quote
|
|
NDC00026-0613-20
|
6505-01-153-3452
|
Usp Plasma Protein Fraction |
Talecris Biotherapeutics Holdings
|
|
Quote
|
|
NDC00026-0613-20
|
6505-01-153-3452
|
Usp Plasma Protein Fraction |
Talecris Biotherapeutics Holdings
|
|
Quote
|
|
NDC00026-0613-20
|
6505-01-153-3452
|
Usp Plasma Protein Fraction |
Talecris Biotherapeutics Holdings
|
|
Quote
|
